Lou Gehrigs Disease - Global Strategic Business Report
- Language: English
- 258 Pages
- Published: April 2010
- Region: World
- Your are here:
- Home
- Categories
- Pharmaceuticals and Healthcare
- Pharmaceuticals
U.S. Neurotherapeutics Markets
U.S. Neurotherapeutics Markets
- Published: November 1997
- Frost & Sullivan
Landmark discoveries in the neurosciences are revolutionizing our understanding of the human brain and its chemical structure. This report from Frost & Sullivan covers new drugs designed to treat such diverse brain disorders as multiple sclerosis, ALS, Alzheimer s dementia, and stroke, as well as treatments for more mature markets. Competitive strategies, such as rereleasing new formulations of existing products, are discussed at length. And profiles for companies like Glaxo-Wellcome, Warner-Lambert, and Parke-Davis are included.
- Executive Summary
- The Richest Pipeline in the Industry
- Summary of Major Findings
- Conclusions
- Industry Challenges and Research Methodology
- Challenges Facing the Pharmaceutical Industry
- Time Frame Analysis of Industry Challenges
| Format | Properties | |
|---|---|---|
| Site License | The report will be emailed to you. The report is sent in PDF format. | This is a site license, allowing all users within a given geographical location of your organisation access to the product. |
| Site License | A copy of the report will be emailed to you and a printed copy will be shipped to you. The Electronic copy is sent in PDF format. | This is a site license, allowing all users within a given geographical location of your organisation access to the product. |
| Enterprisewide | The report will be emailed to you. The report is sent in PDF format. | This is an enterprise license, allowing all employees within your organisation access to the product. |
| Enterprisewide | A copy of the report will be emailed to you and a printed copy will be shipped to you. The Electronic copy is sent in PDF format. | This is an enterprise license, allowing all employees within your organisation access to the product. |
Note: Product cover images may vary from those shown
RELATED PRODUCTS
-
FROM
-
Nitric Oxide - Therapeutics, Markets and Companies
- Language: English
- 274 Pages
- Published: June 2013
- Region: World
FROM -
The Handbook of Alzheimer's Disease and Other Dementias. Blackwell Handbooks of Behavioral Neuroscience
- Language: English
- 648 Pages
- Published: October 2011
-
The Neurodevice 2012 Report: Neuroprosthetics, Neuromodulation, Neurosurgery, Neurovascular Intervention and Neurosoftware
The Neurodevice 2012 Report: Neuroprosthetics, Neuromodulation, Neurosurgery, Neurovascular Intervention and Neurosoftware
- Language: English
- 130 Pages
- Published: May 2012
- Region: World
FROM -
The Neurotechnology Industry 2012 Report
- Language: English
- Published: August 2012
- Region: World
FROM -
Stem Cell Approaches in Neurology and Psychiatry: 25 Trend Setters for 2013 - 3rd Biennial Report
- Language: English
- 200 Pages
- Published: November 2012
- Region: World
FROM -
Dealmaking and Industry Outlook: Neurological Disease
- Language: English
- 37 Pages
- Published: November 2009
- Region: World
FROM -
Emerging Medical Technologies Spotlight
- Language: English
- Published: June 2013
- Region: World
-
Inhaled CNS Therapeutics - Markets & Opportunities
- Language: English
- 100 Pages
- Published: May 2009
- Region: World
FROM -
Amyotrophic Lateral Sclerosis – Analysis and Market Forecasts to 2019
- Language: English
- 75 Pages
- Published: January 2013
- Region: World
FROM
